___

[1] Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92:73-79

[2] Pagano D, Bonser RS, Townend JN, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998; 79: 281–88

[3] Pagano D, Townend JN, Littler WA et al. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791–99

[4] Strauss HW, Miller DD, Wittry MD, et al. Procedure Guideline for Myocardial Perfusion Imaging. J Nucl Med 2008; 36(3):155-61.

[5] Klocke FJ, Baird MG, Lorell BH. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary—a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404–18.

[6] Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation 1981;.63:793-02.

[7] Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665-71.

[8] Toda K, Mackenzie K, Mehra MR, et al. Revascularization in severe ventricular dysfunction (15% LVEF 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg 2002;74: 2082-87.

[9] Koepfli P, Hany TF, Wyss CA. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med 2004;45: 537–42.

[10] Bax JJ, Visser FC, Poldermans D. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 2001;42:79–86

[11] Di Carli MF, Asgarzadie F, Schelbert HR. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92: 3436-44.

[12] Domanski M, Krause-Steinrauf H. The effect of diabetes on outcomes of patient with advenced heart failure in BEST trial. J Am Coll Cardiol 2003; 42:914922.

[13] Topkara VK, Cheema FH, Kesaramanujam S. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005;112:344-50.

[14] Appoo J, Norris C, Merali S. Longterm outcomes of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation 2004;110:13-17.

[15] Robert HJ, Harvey W, Eric JV, Linda KS, et al. Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Enrollment J Am Coll Cardiol 2010; 56(6): 490–98.

[16] Santos BS, Ferreira MJ. Positron emission tomography in ischemic heart disease. Rev Port Cardiol 2019; 38(8): 599-08.

[17] Fukushima K, Arashi H, Minami Y et al. Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by 18F fluorodeoxyglucose positron emission tomography. J Cardiol Cases 2019;20(2): 57-60.